Skip to main content
. 2005 Oct 17;102(43):15653–15658. doi: 10.1073/pnas.0507901102

Table 2. List of candidate genes showing expression changes in MDD and BPD.

Fold change
Gene name Symbol Alias Cytoband AnCg DLPFC
Major depressive disorder
Glial high-affinity glutamate transporter, Na+-dependent SLC1A2 GLT-1; EAAT2 11p13 0.80 0.71
Glial high-affinity glutamate transporter, Na+-dependent SLC1A3 GLAST; EAAT1 5p13 0.85 0.65
Glutamine synthetase GLUL GS 1q31 0.73 0.78
Glutamate receptor, ionotropic, AMPA 1 GRIA1 AMPA1; IGluR1 5q31.1 1.3
Glutamate receptor, ionotropic, AMPA 3 GRIA3 AMPA3; IGluR3 Xq25 1.18
Glutamate receptor, ionotropic, kainate 1 GRIK1 GluR5; EAA3 21q22.11 1.21
Glutamate receptor, ionotropic, kainate 5 GRIK5 GluR-KA2; EAA2 19q13.2 1.14 1.21
GABAA receptor, beta 3 GABARB3 GABAARβ3 15q11.2 1.21
GABAA receptor, delta GABRD GABAA 1p36.3 1.19
GABAA receptor, gamma 2 GABARG2 GABAARγ2 5q3.1 1.22
Bipolar affective disorder
Glutamate receptor, ionotropic GRIA1 AMPA1; IGluR1 5q31.1 1.21
Glutamate receptor, ionotropic GRIA3 AMPA3; IGluR3 Xq25 1.21
Glutamate receptor, ionotropic, kainate 1 GRIK1 GluR5; EAA3 21q22.11 0.78
Glutamate receptor, metabotropic 3 GRM3 mGluR3 7q21.1 1.24 1.26
GABAA receptor, alpha 5 GABRA5 GABAARα5 15q11.2 1.24 1.20
GABAB receptor 1 GABBR1 GABABR1 6p21.31 1.22

Each record indicates the gene name, symbol, common name, cytoband, and fold changes (FC) of expression in the AnCg and/or DLPFC. Expression values, meeting a significance threshold of P ≤ 0.05 and a fold change of ≥1.175 were considered increases, and those with a fold change of ≤0.85 were considered decreases.

  NODES